October 31 – November 2, 2019
Dear colleagues, We would like to extend a warm welcome to you on behalf of the organisational team behind the next EORTC Gastrointestinal Tract Cancer Group Meeting on 31stOctober to 2nd November, 2019 in Tallinn, Estonia.
The meeting will take place in the House of Black Heads in Tallinn’s vibrant medieval Old Town.
Please find here more information about accommodation options. You can find the detailed programme of the event below. We kindly ask you to book the event in your calendars.
Looking forward to seeing everyone in Tallinn!
On behalf of the organisational team,
The venue takes place in the House of the Black Heads – One of the oldest and most renowned building complexes in Tallinn’s Old Town.
House of the Black Heads is one of the oldest and most renowned building complexes in Tallinn’s Old Town. The most unique rooms are the White Hall (1532), which is the first venue in Renaissance style in Tallinn, and the St. Olaf’s Guild Hall (1422), built in the late Gothic style.
The long history of the brotherhood is full of legends of saints, soldiers, and adventurers, which are nowadays primarily reflected in the names of the premises. The House of the Blackheads is located in the historic gathering place of Tallinn’s former merchants and craftsmen’s associations.
Welcome and introduction
F. Lordick / E. Smyth
Esophagus + Stomach Cancer
M. Moehler / D. Wagner
Hepatobiliary, Pancreas and NET Cancer
J. W. Valle / J. Ricke
Colorectal Cancer / CRC IMMUCAN
M. Peeters / T. Kössler/ F. Sclafani
Rectum & Anal Cancer
D. Arnold / L. Wyrwicz
Adolescents and Young Adults (AYA)
I. Ben Aharon / E. Fontana
SPECTA and Early Phase trials
R. Obermannova / M. Alsina
Business Meeting (restricted to Group members taking part in the strategy meetings)
Report from Task Force Sessions OR HQ Update
Young Investigators Program
A.Roth / R. Salazar / J. Barriuso / S. Markar
Protocols in development/regulatory submission
- EORTC 1607 PEMBRO
- EORTC 1715 TELEFIRST
- SPECTA – RP 1904 LMGC
- EORTC 1912 PAMICC (tbc if HQ greenlight at time of meeting)
- EORTC 1925 PANORAMA (tbc if HQ greenlight at time of meeting)
- EORTC 1927 CIRCULATE
- EORTC 1933 Pancreas SBRT (w or w/o Nanoparticles (tbc if board approved)
- EORTC 1937 Somatuline in Net-LM (tbc if strategic approval)
- EORTC 1938 1L Gastric cancer – Servier (tbc if strategic approval)
- Incidental gallbladder
- EORTC 1741 DYNAMIC (tbc)
- EORTC 1714 CRUCIAL
- EORTC 1707 VESTIGE (tbc)
- EORTC 1560 ILOC
- EORTC 1527 DREAM
- EORTC 1203 INNOVATION
- EORTC 1534 SAKK 41/13 – ASPIRIN
- EORTC 22114-40111 TOP GEAR
Studies closed for recruitment
- EORTC 1409 CLIMB
Interaction between neoadjuvant therapies, comorbidity and surgery, in relation to surgical short-term and oncological long-term outcomes
Systemic therapy of advanced gastric cancer – do markers and patient characteristics guide treatment
How molecular biology informs contemporary treatment of Crc
Early Onset Colorectal Cancer – Changing Face of a Common disease
Repeated centralised resectability assessment in 1086 Finnish metastatic colorectal cancer patients (the RAXO study)
Anal Cancer – who to expand treatment options in the International Rare Cancer Initiative
Closing remarks: Perspective for the Future of GI Cancer research
Use the code BEORTCGI19 when registering:
Registration is now open. Sign up for the event here: